Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR

por Dyrskjøt, L, Reinert, T, Novoradovsky, A, Zuiverloon, T C M, Beukers, W, Zwarthoff, E, Malats, N, Real, F X, Segersten, U, Malmström, P-U, Knowles, M, Hurst, C, Sorge, J, Borre, M, Ørntoft, T F
Publicado 2012

Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models

por López de Maturana, E., Picornell, A., Masson-Lecomte, A., Kogevinas, M., Márquez, M., Carrato, A., Tardón, A., Lloreta, J., García-Closas, M., Silverman, D., Rothman, N., Chanock, S., Real, F. X., Goddard, M. E., Malats, N.
Publicado 2016

LINE-1 methylation in leukocyte DNA, interaction with phosphatidylethanolamine N-methyltransferase variants and bladder cancer risk

por Tajuddin, S M, Amaral, A F S, Fernández, A F, Chanock, S, Silverman, D T, Tardón, A, Carrato, A, García-Closas, M, Jackson, B P, Toraño, E G, Márquez, M, Urdinguio, R G, García-Closas, R, Rothman, N, Kogevinas, M, Real, F X, Fraga, M F, Malats, N
Publicado 2014